Quarterly report pursuant to Section 13 or 15(d)

Selected Balance Sheet Data (Tables)

v3.22.1
Selected Balance Sheet Data (Tables)
9 Months Ended
Mar. 31, 2022
Notes Tables  
Schedule of Inventory, Current [Table Text Block]

Inventories consist of (in thousands):

    

March 31, 

June 30, 

    

2022

    

2021

Raw materials

$

69,263

$

55,096

Finished goods(1)

 

64,742

 

67,108

Inventories, net

$

134,005

$

122,204

(1) Finished goods inventory of $5,722 and $5,456 included within other long-term assets in the respective March 31, 2022 and June 30, 2021, consolidated balance sheet. The inventory is included in long-term assets as it is forecasted to be sold after the 12 months subsequent to the consolidated balance sheet date.

Property, Plant and Equipment [Table Text Block]

Property and equipment consist of (in thousands):

    

March 31, 

June 30, 

    

2022

    

2021

Land

$

8,603

$

8,612

Buildings and improvements

 

225,378

 

190,661

Machinery and equipment

164,665

149,410

Construction in progress

 

26,508

 

49,073

Property and equipment, cost

 

425,154

 

397,756

Accumulated depreciation and amortization

 

(206,756)

 

(189,849)

Property and equipment, net

$

218,398

$

207,907

Schedule of Intangible Assets and Goodwill [Table Text Block]

Intangible assets consist of (in thousands):

March 31, 

June 30, 

2022

2021

Developed technology

$

543,977

$

552,160

Trade names

 

147,311

 

147,640

Customer relationships

 

228,943

 

232,493

Patents

 

3,249

 

2,926

Other intangibles

 

6,313

 

6,316

Definite-lived intangible assets

 

929,793

 

941,535

Accumulated amortization

 

(401,151)

 

(348,267)

Definite-lived intangibles assets, net

 

528,642

 

593,268

In process research and development

 

22,700

 

22,700

Total intangible assets, net

$

551,342

$

615,968

Schedule of Finite-Lived Intangible Assets [Table Text Block]

Changes to the carrying amount of net intangible assets for the period ended March 31, 2022 consist of (in thousands):

Beginning balance

$

615,968

Acquisitions

 

Other additions

 

283

Amortization expense

 

(55,731)

Currency translation

 

(615)

Eminence impairment (1)

(8,563)

Ending balance

$

551,342

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]

The estimated future amortization expense for intangible assets as of March 31, 2022 is as follows (in thousands):

2022 remainder

    

$

18,478

2023

 

71,725

2024

 

68,857

2025

 

65,621

2026

 

61,876

Thereafter

 

242,085

Total

$

528,642

(1) As disclosed in Note 1, the Company recorded an impairment charge of $8.6 million related to Eminence in Q2 of FY'22.

Schedule of Goodwill [Table Text Block]

Changes to the carrying amount of goodwill for the period ended March 31, 2022 consist of (in thousands):

    

    

Diagnostics and

    

Protein Sciences

 Genomics

Total

Beginning balance

$

392,717

$

450,350

$

843,067

Acquisitions(1)

 

 

(4,407)

 

(4,407)

Eminence impairment

(8,275)

(8,275)

Currency translation

 

(2,588)

 

(179)

 

(2,767)

Ending balance

$

381,854

$

445,764

$

827,618